Why Novavax is the dark-horse COVID-19 vaccine
Posted on
Novavax s shot could become the next coronavirus vaccine in the U.S. arsenal, potentially jumping ahead of AstraZeneca in the line for U.S. authorization, Politico reports.
Why it matters: The vaccine proved to be just as effective as Pfizer and Moderna s mRNA vaccines in a U.K. clinical trial, and could become a crucial tool in the global vaccination effort.
Between the lines: Novavax has never brought a product to market before, and began last-state clinical trials months after some of the other candidates.
But AstraZeneca s rollout has been plagued by a series of public relations mishaps, and it along with Johnson & Johnson s shot has been linked to rare but serious blood clots. J&J is also facing production concerns in the U.S.